Kexiang X. Yan
No. 12 Wulumuqi Road
Shanghai, 200040, China
Shanghai, 200040, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Efficacy and safety of vunakizumab in patients with moderate-to-severe plaque psoriasis with a high drug interruption rate during the COVID-19 pandemic: a post hoc analysis from a single center of a phase III trial.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: April 16, 2026
Lesional sweat interleukin-17A reflects local inflammatory activity and treatment response in plaque psoriasis.
Journal: The British journal of dermatology
Published: April 01, 2026
PD-1 Engagement and Circulating Th17 Effector Activity During Secukinumab Treatment in Plaque Psoriasis.
Journal: Clinical and experimental immunology
Published: February 23, 2026
Vunakizumab for IL-17A-Mediated Diseases: A Review in Psoriasis and Spondyloarthritis.
Journal: Biologics : targets & therapy
Published: January 31, 2026
TYK2 and IL-23 Pathway Therapies in Psoriasis: Associations With IL-6, Tryptophan Metabolism, and Depressive Symptoms.
Journal: International journal of dermatology
Published: July 29, 2025
Psoriasis modulates inflammatory bowel disease risk and intestinal epithelium lipid metabolism via IL-1β-producing macrophages.
Journal: Cell metabolism
Published: April 25, 2025
Evaluation of β2-microglobulin in the condition and prognosis of psoriasis patients.
Journal: The Journal of dermatological treatment
Published: July 28, 2024
Efficacy and safety of vunakizumab in moderate-to-severe chronic plaque psoriasis: A randomized, double-blind, placebo-controlled phase 3 trial.
Journal: Journal of the American Academy of Dermatology
Published: May 03, 2024
Differential expression of plasma extracellular vesicle miRNAs as biomarkers for distinguishing psoriatic arthritis from psoriasis.
Journal: Chinese medical journal
Published: November 24, 2023
Identification of an exosomal miRNA-mRNA regulatory network contributing to methotrexate efficacy.
Journal: International immunopharmacology
Published: August 12, 2023
Unlocking the role of the B7-H4 polymorphism in psoriasis: Insights into methotrexate treatment outcomes: A prospective cohort study.
Journal: Immunology
Published: June 25, 2023
MicroRNA-125a-5p regulates the effect of Tregs on Th1 and Th17 through targeting ETS-1/STAT3 in psoriasis.
Journal: Journal of translational medicine
Published: June 10, 2023
Last Updated: 09/26/2026